Fuse Medical, Inc. Announces Fiscal Year 2020 Financial Results
Retrieved on:
Friday, April 2, 2021
Fuses 2020 has proved to be an exception and pivotal for Fuses growth as a Manufacturer and innovative product developer.
Key Points:
- Fuses 2020 has proved to be an exception and pivotal for Fuses growth as a Manufacturer and innovative product developer.
- In November 2020, Deloitte recognized our Company for our fast growth with a ranking of forty-third (43rd) on their 2020 Technology Fast 500TM.
- In December 2020, we launched FuseChoiceTM, FuseChoiceTM Plus, and FuseChoiceTM Max, part of our amniotic and umbilical membrane product line.
- In February 2021, we launched our Fuse ACP Anterior Cervical Plating System, expanding our offerings in our Spine division.